The CD47 protein is highly expressed in various types of cancers, including acute and chronic myeloid leukemia, non-Hodgkin lymphomas, multiple myeloma, leiomyosarcoma, glioblastoma, and carcinomas of the bladder, ovary, prostate, breast, and colon. Here, CD47 is linked to plasma cell myeloma.